PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Reversion Plays 10Y Sharpe
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


ABBV 10%ARGX 10%HCA 10%MRNA 10%TMUS 10%UNH 10%WRB 10%KNSL 10%ADP 10%ELV 10%EquityEquity
PositionCategory/SectorTarget Weight
ABBV
AbbVie Inc.
Healthcare
10%
ADP
Automatic Data Processing, Inc.
Industrials
10%
ARGX
argenx SE
Healthcare
10%
ELV
Elevance Health Inc
Healthcare
10%
HCA
HCA Healthcare, Inc.
Healthcare
10%
KNSL
Kinsale Capital Group, Inc.
Financial Services
10%
MRNA
Moderna, Inc.
Healthcare
10%
TMUS
T-Mobile US, Inc.
Communication Services
10%
UNH
UnitedHealth Group Incorporated
Healthcare
10%
WRB
W. R. Berkley Corporation
Financial Services
10%

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Reversion Plays 10Y Sharpe, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.


100.00%150.00%200.00%250.00%NovemberDecember2025FebruaryMarchApril
248.48%
100.36%
Reversion Plays 10Y Sharpe
Benchmark (^GSPC)
Portfolio components

The earliest data available for this chart is Dec 7, 2018, corresponding to the inception date of MRNA

Returns By Period


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
-10.30%-7.04%-9.70%4.44%12.96%9.77%
Reversion Plays 10Y Sharpe3.85%-0.51%-1.86%6.33%21.05%N/A
ABBV
AbbVie Inc.
-1.58%-19.21%-8.17%9.47%20.42%15.41%
ARGX
argenx SE
-1.57%-1.44%11.98%63.31%33.48%N/A
HCA
HCA Healthcare, Inc.
10.53%0.77%-18.76%6.30%24.49%16.37%
MRNA
Moderna, Inc.
-39.42%-27.43%-56.16%-75.73%-11.71%N/A
TMUS
T-Mobile US, Inc.
18.02%-0.20%18.97%64.78%24.01%23.60%
UNH
UnitedHealth Group Incorporated
16.15%17.24%3.23%26.77%16.78%19.14%
WRB
W. R. Berkley Corporation
17.12%6.82%16.73%28.11%24.55%19.01%
KNSL
Kinsale Capital Group, Inc.
4.02%5.90%2.70%7.09%33.88%N/A
ADP
Automatic Data Processing, Inc.
1.02%-0.82%2.25%23.04%18.35%15.94%
ELV
Elevance Health Inc
18.42%1.03%-11.73%-12.95%11.61%12.60%
*Annualized

Monthly Returns

The table below presents the monthly returns of Reversion Plays 10Y Sharpe, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20252.30%-0.28%4.27%-2.37%3.85%
20247.05%5.92%4.63%-10.30%8.45%-1.90%9.85%-1.30%-2.19%-3.54%4.65%-6.84%12.89%
2023-0.37%-6.09%2.28%-1.47%-4.69%4.76%4.51%-0.03%-1.40%-9.97%3.35%2.01%-7.96%
2022-19.60%0.42%9.29%-10.01%3.97%1.12%6.11%-5.25%-5.33%17.69%5.94%-4.13%-5.02%
202113.53%-2.15%-4.95%14.59%2.08%10.15%24.02%4.27%-2.03%-2.40%0.18%-7.46%55.97%
2020-1.15%1.44%-9.58%16.16%20.46%1.49%9.51%0.37%0.35%-1.97%40.78%-11.68%73.10%
20196.49%8.36%-2.04%4.04%-1.17%1.88%0.29%-0.43%-0.98%5.27%5.70%2.43%33.44%
2018-5.62%-5.62%

Expense Ratio

Reversion Plays 10Y Sharpe has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of Reversion Plays 10Y Sharpe is 71, indicating average performance compared to other portfolios on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of Reversion Plays 10Y Sharpe is 7171
Overall Rank
The Sharpe Ratio Rank of Reversion Plays 10Y Sharpe is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of Reversion Plays 10Y Sharpe is 7272
Sortino Ratio Rank
The Omega Ratio Rank of Reversion Plays 10Y Sharpe is 6969
Omega Ratio Rank
The Calmar Ratio Rank of Reversion Plays 10Y Sharpe is 8282
Calmar Ratio Rank
The Martin Ratio Rank of Reversion Plays 10Y Sharpe is 6060
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for Portfolio, currently valued at 0.36, compared to the broader market-4.00-2.000.002.00
Portfolio: 0.36
^GSPC: 0.22
The chart of Sortino ratio for Portfolio, currently valued at 0.61, compared to the broader market-6.00-4.00-2.000.002.004.00
Portfolio: 0.61
^GSPC: 0.44
The chart of Omega ratio for Portfolio, currently valued at 1.08, compared to the broader market0.400.600.801.001.201.401.60
Portfolio: 1.08
^GSPC: 1.06
The chart of Calmar ratio for Portfolio, currently valued at 0.24, compared to the broader market0.001.002.003.004.005.00
Portfolio: 0.24
^GSPC: 0.22
The chart of Martin ratio for Portfolio, currently valued at 1.22, compared to the broader market0.005.0010.0015.0020.00
Portfolio: 1.22
^GSPC: 1.02

Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
ABBV
AbbVie Inc.
0.380.641.100.501.28
ARGX
argenx SE
1.822.621.321.7410.94
HCA
HCA Healthcare, Inc.
0.120.351.050.120.23
MRNA
Moderna, Inc.
-1.10-2.210.74-0.80-1.25
TMUS
T-Mobile US, Inc.
2.793.341.524.4913.97
UNH
UnitedHealth Group Incorporated
1.121.591.231.293.09
WRB
W. R. Berkley Corporation
1.181.591.232.125.58
KNSL
Kinsale Capital Group, Inc.
0.210.561.090.240.68
ADP
Automatic Data Processing, Inc.
1.231.731.241.826.89
ELV
Elevance Health Inc
-0.44-0.440.94-0.34-0.59

The current Reversion Plays 10Y Sharpe Sharpe ratio is 0.67. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 0.20 to 0.76, this portfolio's current Sharpe ratio lies between the 25th and 75th percentiles. This indicates that the its risk-adjusted performance is in line with the majority of portfolios. This suggests a balanced approach to risk and return, which might be suitable for a broad range of investors.

Use the chart below to compare the Sharpe ratio of Reversion Plays 10Y Sharpe with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.36
0.22
Reversion Plays 10Y Sharpe
Benchmark (^GSPC)
Portfolio components

Dividends

Dividend yield

Reversion Plays 10Y Sharpe provided a 1.28% dividend yield over the last twelve months.


TTM20242023202220212020201920182017201620152014
Portfolio1.28%1.35%1.29%0.99%1.09%1.04%1.31%1.30%0.98%1.16%1.00%1.02%
ABBV
AbbVie Inc.
3.72%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%
ARGX
argenx SE
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
HCA
HCA Healthcare, Inc.
0.82%0.88%0.89%0.93%0.75%0.47%1.08%1.12%0.00%0.00%0.00%0.00%
MRNA
Moderna, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TMUS
T-Mobile US, Inc.
1.18%1.28%0.41%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UNH
UnitedHealth Group Incorporated
1.44%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%1.39%
WRB
W. R. Berkley Corporation
2.05%2.39%2.73%1.22%2.44%0.71%2.43%2.83%2.16%2.27%0.86%2.79%
KNSL
Kinsale Capital Group, Inc.
0.13%0.13%0.17%0.20%0.18%0.18%0.31%0.50%0.53%0.29%0.00%0.00%
ADP
Automatic Data Processing, Inc.
2.00%1.96%2.21%1.83%1.55%2.08%1.92%2.14%2.00%2.10%2.36%2.10%
ELV
Elevance Health Inc
1.52%1.77%1.26%1.00%0.98%1.18%1.06%1.14%1.20%1.81%1.79%1.39%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-20.81%
-14.13%
Reversion Plays 10Y Sharpe
Benchmark (^GSPC)
Portfolio components

Worst Drawdowns

The table below displays the maximum drawdowns of the Reversion Plays 10Y Sharpe. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Reversion Plays 10Y Sharpe was 42.12%, occurring on Jan 27, 2022. The portfolio has not yet recovered.

The current Reversion Plays 10Y Sharpe drawdown is 5.70%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-42.12%Aug 10, 2021119Jan 27, 2022
-29.03%Feb 20, 202023Mar 23, 202032May 7, 202055
-15.97%Feb 12, 202132Mar 30, 202119Apr 27, 202151
-14.99%Dec 9, 202016Dec 31, 202023Feb 4, 202139
-12.28%Dec 14, 20187Dec 24, 201825Jan 31, 201932

Volatility

Volatility Chart

The current Reversion Plays 10Y Sharpe volatility is 9.04%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
9.04%
13.66%
Reversion Plays 10Y Sharpe
Benchmark (^GSPC)
Portfolio components

Diversification

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

MRNAARGXKNSLABBVTMUSHCAWRBUNHELVADP
MRNA1.000.230.130.140.130.120.040.060.080.17
ARGX0.231.000.190.230.250.220.130.190.180.24
KNSL0.130.191.000.210.300.270.490.220.220.41
ABBV0.140.230.211.000.260.320.290.340.370.35
TMUS0.130.250.300.261.000.300.340.310.310.41
HCA0.120.220.270.320.301.000.390.380.430.42
WRB0.040.130.490.290.340.391.000.340.380.48
UNH0.060.190.220.340.310.380.341.000.740.38
ELV0.080.180.220.370.310.430.380.741.000.38
ADP0.170.240.410.350.410.420.480.380.381.00
The correlation results are calculated based on daily price changes starting from Dec 10, 2018
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab